Antonazzo, Ippazio Cosimo
Gribaudo, Giorgia https://orcid.org/0000-0002-5034-7446
Ye, Lisa
Ferrara, Pietro
Losa, Lorenzo
Abrate, Paolo
Iraldo, Fabio
Mantovani, Lorenzo Giovanni
Cortesi, Paolo Angelo
Article History
Accepted: 3 June 2025
First Online: 23 June 2025
Declarations
:
: ICA, GG, LY, and LL declare no conflicts of interest. PF has received compensation for consulting services from Seqirus. FI has received grants from Menarini, Bracco, and Angelini Pharma. PA received a grant from Roche. PAC has received a research grant from Baxalta, now part of Shire, and speaking honoraria from Pfizer and Roche. LGM has received grants and personal fees from Bayer AG, Boehringer Ingelheim, Pfizer, and Daiichi-Sankyo.
: No funding was received for this work.
: Not applicable.
: Conceptualization: ICA, PAC, and LGM. Methodology: ICA, GG, LY, and PAC. Data curation: ICA, GG, and LY. Writing—original draft preparation: ICA, GG, and PAC. Writing—review and editing: all authors. All authors have read and agreed to the published version of the article.
: Not applicable.
: Not applicable.
: All data and material were included in the article.
: Not applicable.